AI-driven pre-screening for colorectal cancer using complete blood counts: toward broader population impact

利用全血细胞计数进行人工智能驱动的结直肠癌预筛查:旨在扩大人群影响

阅读:2

Abstract

PURPOSE: Early colorectal cancer (CRC) detection is crucial for effective treatment; however, traditional screening methods face challenges. Colonoscopy, though highly effective, has limited availability, and fecal immunochemical tests (FIT) are more accessible and cost-effective but suffer from low adherence. Our retrospective study aimed to develop a transparent artificial-intelligence model leveraging routine CBC data as a cost-effective method for CRC detection. METHODS: We conducted a retrospective analysis of 28,450 individuals aged 45-75 who underwent colonoscopy within six months of a complete blood count (CBC) test. Among them, 439 (1.8%) had CRC, 2,955 (11.8%) had advanced adenomas, and 21,662 (86.5%) had benign findings on colonoscopy. The database was divided into training (70%) and testing (30%) sets. The model was developed using ridge regression. RESULTS: Descriptive analysis revealed significant differences between CRC cases and controls across most CBC markers, CBC-derived ratios, and age (P < 0.001), except for lymphocytes. The model, based on red cell distribution width (RDW), systemic inflammation response index (SIRI), hemoglobin, and age, achieved an AUC of 0.77 (95% CI: 0.75-0.77) for CRC, comparable to a deep learning model (TabPFN). Interpretability analysis revealed that older age, elevated RDW and SIRI, and low hemoglobin were associated with CRC. In a subgroup (7.25%) with FIT results, FIT showed higher sensitivity for CRC (88%) than the model (64%), but lower specificity (77% vs. 81%). CONCLUSION: Given CBC's widespread use and accessibility, this approach may be a scalable pre-screening tool to improve CRC risk stratification and optimize resource allocation, demonstrating how explainable AI may augment existing CRC screening programs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。